Trade Summary

3 days ago, Mainolfi Nello, serving as Chief Executive Officer at Kymera Therapeutics, Inc. (KYMR), sold 50,000 shares at $119.00 per share, for a total transaction value of $5,950,000.00. Following this transaction, Mainolfi Nello now holds 666,568 shares of KYMR.

This sale represents a 6.98% decrease in Mainolfi Nello's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, July 7, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, July 8, 2026 (accepted Jul 7, 8:00 PM ET), 1 day after the trade was made.

Kymera Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.